Experimental Labour—offshoring Clinical Trials to China
Datos Bibliográficos
| ID | 15674459 |
|---|---|
| Autores | M Cooper (0000-0001-8341-8282, The University of Sydney, autor de correspondencia) |
| Año | 2008 |
| Volumen | 2 |
| Número | 1 |
| Páginas | 73-92 |
| Fecha de publicación | 2008-03-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | East Asian Science Technology and Society An International Journal (JOURNAL) |
| Identificadores de la revista | ISSN: 1875-2152 • E-ISSN: 1875-2160 |
| Editorial | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1215/s12280-008-9040-y |
| OpenAlex | W4206556799 |
| Idioma | EN |
| Citas recibidas | 16 |
| Referencias citadas | 25 |
The State Food and Drug Administration of China has reported a dramatic increase in multicentre, multinational clinical trials over the past several years. This is in keeping with a growing trend towards the off-shore outsourcing of clinical trials from North America and Western Europe to `nontraditional locations' such as Eastern Europe, China, and India. Within China, the post-socialist reform of health care, internal divisions of labour and the politicization of the healthcare system have all created the conditions under which contract clinical trial work is becoming an imperative both for hospitals and the growing number of working uninsured. The paper brings together a critical insight into current theories of bioeconomic innovation with new political economies of informal labour and offshoring. It argues that the clinical trial phase in the production of bioeconomic value is routinely overlooked in scholarly accounts but is key to understanding the speculative overinvestment and translational difficulties of the pharmaceutical industries today. As a way of reformulating the problem, the paper suggests that human subject experimentation would be more fruitfully reconfigured as a form of labour—experimental or clinical labour. The research hospital clinic therefore emerges as an export labour zone in `experimental body work
Business · China · Clinical trial · Economic growth · Economics · Health care · Multinational corporation · Offshoring · Outsourcing · Pharmaceutical industry · Political science · Politics · Value (mathematics · Work (physics · Biomedical Ethics and Regulation · Biotechnology and Related Fields · Engineering · Ethics in Clinical Research · Law · Medicine · Marketing
Seizing the opportunity
Regulating clinical trials in India
Biomedical Innovation and the Geopolitics of Patenting
Modalities of value, exchange, solidarity
Taking care
(Re)configuring research value
Evidence-based medicine and private clinics in Russia
Experimental stem cell therapy
In the mood for science
Globalising knowledge networks
Experimental Republic
Challenging Assumptions About Minority Participation in US Clinical Research
What is the impact of patient recruitment on offshoring of clinical trials
Standardization as situation-specific achievement
Fast, cheap, and out of control? Speculations and ethical concerns in the conduct of outsourced clinical trials in India
In/dependent Collaborations
Biocapital
Inclusion
Privatization and Its Discontents — The Evolving Chinese Health Care System
Governing China's Population
Clinical Trials Offshored
The Contract Research Organization and the Commercialization of Scientific Research
Experimental Complexity in Biology
The Biopolitics of Reproduction
Strange circulations
| Obras citantes distintas | 16 |
|---|---|
| Citas por año | 1,07 |
| Intervalo de citas | 2011 - 2026 (16) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 16 |